Radiofrequency ablation of renal allograft cancer: Case report
Abdugafarov S. Assykbayev M. Sharmenov A. Kalzhan A. Saparbay J.
2021National Scientific Medical Center
Journal of Clinical Medicine of Kazakhstan
2021#18Issue 362 - 64 pp.
Renal cell carcinoma of an allograft kidney is an extremely rare type of neoplasm and accounts for about 0.22-0.5% of all kidney recipients. Kidney recipients undergo routine check-up, including ultrasound examination of the graft. Renal cell carcinoma is often asymptomatic and can be an incidental finding on routine examination. In this case study, we describe a patient who developed clear cell carcinoma 9 months after the kidney transplantation from a living related donor. Radiofrequency ablation was chosen as the treatment option, considering small size solitary lesions in a renal allograft. The complete ablative response was achieved after one treatment. In a 4-year follow-up period patient did not show any new or recurrent tumor. Radiofrequency ablation is a good therapeutic option for kidney allograft carcinoma.
immunosuppression , kidney ablation , kidney transplant cancer , kidney transplantation
Text of the article Перейти на текст статьи
Department of Oncohepatology, Gastroenterology and Organ Transplantation, National Research Oncology Center, Nur-Sultan city, Kazakhstan
Medical School, Medical University Astana, Nur-Sultan city, Kazakhstan
Department of Oncohepatology
Medical School
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026